China Universal Asset Management »

Theravance Biopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $86k 9.6k 8.97
2023-12-31 $65k 5.8k 11.29
2023-09-30 $12k 1.4k 8.84
2023-06-30 $8.0k 757 10.57
2023-03-31 $10k 913 10.95
2022-12-31 $8.0k 684 11.70
2022-09-30 $7.0k 716 9.78

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Vanguard Group
Newtyn Management
Park West Asset Management
D. E. Shaw & Co
Bank of America Corporation
Jacobs Levy Equity Management
Jane Street
Charles Schwab Investment Management
Wellington Management Company
Goldman Sachs Group
Chescapmanager
SG Americas Securities
Highbridge Capital Management

View all funds holding Theravance Biopharma